# Ypsomed signs long-term supply agreement with Novo Nordisk for autoinjectors

Ypsomed concluded a long-term supply agreement with Novo Nordisk for large quantities of YpsoMate 1ml autoinjectors for metabolic disease self-treatment. Novo Nordisk will contribute a significant part of the investment for new production infrastructure, with first capacity available in 2025.

- Type: Contract
- Announced: 2023-09-20
- Where: Switzerland
- Status: announced
- Products: autoinjectors
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md) (supplier)
- [Novo Nordisk](https://endata.com/companies/17868.md) (customer)

## Sources

- [ypsomed.com](https://www.ypsomed.com/en/investors/ad-hoc-announcements/ad-hoc-detail-page/ypsomed-concludes-a-long-term-supply-agreement-for-large-quantities-of-autoinjectors), 2023-09-20: "The conclusion of this contract marks an important milestone for Ypsomed."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.